The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience. [PDF]
Juozaityte V +8 more
europepmc +1 more source
Memantine as an Adjuvant in Cognitive Symptoms of Schizophrenia with a Chronic Course: A Follow-up Study. [PDF]
Salaam MA, Koyilada G, Kiran DR.
europepmc +1 more source
Prescribing memantine in general practice in England: a mixed-methods study. [PDF]
Carter M, Butterworth J, Fox C, Allan L.
europepmc +1 more source
Memantine and graded motor imagery for complex regional pain syndrome (MEMOIR): study protocol and statistical analysis plan for a decentralised, 2 × 2 factorial randomised trial. [PDF]
Ferraro MC +15 more
europepmc +1 more source
Memantine Confers Multi-Target Protection in a Zebrafish Seizure Model: Attenuating Epileptic Behavior, GluN2A Overexpression, and Oxidative Stress. [PDF]
Zenki KC +9 more
europepmc +1 more source
Memantine treatment improves opioid-induced hyperalgesia symptoms: randomize clinical trial. [PDF]
Anjomshoaa A +4 more
europepmc +1 more source
The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis. [PDF]
Liu Y +5 more
europepmc +1 more source
Memantine, an NMDA Receptor Antagonist, Attenuates Doxorubicin-Induced Cardiac Oxidative Stress and Inflammation in Mouse 4T1 Breast Cancer Model. [PDF]
Ghafouri-Asbagh A +6 more
europepmc +1 more source
Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias. [PDF]
Deng H +9 more
europepmc +1 more source
Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]
Chen C +5 more
europepmc +1 more source

